In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview RiaSTAP is approved by the Food and Drug Administration (FDA) to treat acute bleeding episodes in people with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The technical… read more
Join